Abstract: The present embodiments relate generally to the field of cancer diagnostics. More specifically the embodiments relate to platelet derived biomarkers used for diagnosis of cancer or cancer progression, as well as prognosis and improved treatment.
Type:
Grant
Filed:
January 22, 2014
Date of Patent:
August 21, 2018
Assignee:
NEOPROTEOMICS AB
Inventors:
Bo Franzèn, Gert Auer, Susanne Becker, Marta Lomnytska, Timo Gemoll, Jens Habermann